To the Editor: After publication of our peer-reviewed perspective article on the safe and effective use of domperidone in the management of low milk supply,1 we are disappointed to have been informed that the Australian medicines handbook (AMH) has removed lactation stimulation as a recognised off-label indication for domperidone (as well as metoclopramide). It appears that this change could be a kneejerk response to recent regulatory warnings, despite these being highlighted as not being of relevance to most breastfeeding women.1,2 These changes carry with them the significant potential to create confusion among prescribers and the public.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Grzeskowiak LE, Amir LH. Pharmacological management of low milk supply with domperidone: separating fact from fiction. Med J Aust 2014; 201: 257-258. <MJA full text>
- 2. Grzeskowiak L. Use of domperidone to increase breast milk supply: are women really dying to breastfeed? J Hum Lact 2014; 30: 498-499.
- 3. Grzeskowiak LE, Lim SW, Thomas AE, et al. Audit of domperidone use as a galactogogue at an Australian tertiary teaching hospital. J Hum Lact 2013; 29: 32-37.
- 4. State Government of Victoria, Department of Education and Early Childhood Development. Promoting breastfeeding. Victorian Breastfeeding Guidelines. Melbourne: Department of Education and Early Childhood Development, 2014. http://www.education.vic.gov.au/Documents/childhood/professionals/health/brestfeedguidelines14.pdf (accessed Nov 2014).
Luke Grzeskowiak acknowledges salary support from a National Health and Medical Research Council Australian Public Health Fellowship (ID1070421).
No relevant disclosures.